Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

More prominent muscle involvement in patients with dermatomyositis with anti-Mi2 autoantibodies.

Pinal-Fernandez I, Mecoli CA, Casal-Dominguez M, Pak K, Hosono Y, Huapaya J, Huang W, Albayda J, Tiniakou E, Paik JJ, Johnson C, Danoff SK, Corse AM, Christopher-Stine L, Mammen AL.

Neurology. 2019 Nov 5;93(19):e1768-e1777. doi: 10.1212/WNL.0000000000008443. Epub 2019 Oct 8.

PMID:
31594859
2.

Myositis Autoantibodies: A Comparison of Results from the Oklahoma Medical Research Foundation Myositis Panel to the Euroimmun Research Line Blot.

Mecoli CA, Casal-Dominguez M, Pak K, Pinal-Fernandez I, Albayda J, Tiniakou E, Paik JJ, Zahid U, Danoff SK, Mammen AL, Casciola-Rosen L, Christopher-Stine L.

Arthritis Rheumatol. 2019 Aug 20. doi: 10.1002/art.41088. [Epub ahead of print]

PMID:
31430029
3.

Long-Term Treatment With Azathioprine and Mycophenolate Mofetil for Myositis-Related Interstitial Lung Disease.

Huapaya JA, Silhan L, Pinal-Fernandez I, Casal-Dominguez M, Johnson C, Albayda J, Paik JJ, Sanyal A, Mammen AL, Christopher-Stine L, Danoff SK.

Chest. 2019 Nov;156(5):896-906. doi: 10.1016/j.chest.2019.05.023. Epub 2019 Jun 22.

PMID:
31238042
4.

Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis.

Shin JY, Beckett JD, Bagirzadeh R, Creamer TJ, Shah AA, McMahan Z, Paik JJ, Sampedro MM, MacFarlane EG, Beer MA, Warren D, Wigley FM, Dietz HC.

Sci Transl Med. 2019 Jun 19;11(497). pii: eaaw0790. doi: 10.1126/scitranslmed.aaw0790.

PMID:
31217334
5.

Long-term treatment with human immunoglobulin for antisynthetase syndrome-associated interstitial lung disease.

Huapaya JA, Hallowell R, Silhan L, Pinal-Fernandez I, Casal-Dominguez M, Johnson C, Albayda J, Paik JJ, Lin CT, Hussien A, Mammen AL, Christopher-Stine L, Danoff SK.

Respir Med. 2019 Jul - Aug;154:6-11. doi: 10.1016/j.rmed.2019.05.012. Epub 2019 May 21.

PMID:
31176796
6.

Pattern of muscle involvement in inclusion body myositis: a sonographic study.

Albayda J, Christopher-Stine L, Bingham Iii CO, Paik JJ, Tiniakou E, Billings S, Uy OM, Burlina P.

Clin Exp Rheumatol. 2019 May-Jun;37(3):518. Epub 2019 May 21. No abstract available.

7.

Efficacy and adverse effects of methotrexate compared with azathioprine in the antisynthetase syndrome.

Casal-Dominguez M, Pinal-Fernandez I, Huapaya J, Albayda J, Paik JJ, Johnson C, Silhan L, Mammen AL, Danoff SK, Christopher-Stine L.

Clin Exp Rheumatol. 2019 Sep-Oct;37(5):858-861. Epub 2019 Apr 29.

8.

The ILD-GAP risk prediction model performs poorly in myositis-associated interstitial lung disease.

Brusca RM, Pinal-Fernandez I, Psoter K, Paik JJ, Albayda J, Mecoli C, Tiniakou E, Mammen AL, Christopher-Stine L, Danoff S, Johnson C.

Respir Med. 2019 Apr;150:63-65. doi: 10.1016/j.rmed.2019.02.015. Epub 2019 Feb 21.

PMID:
30961952
9.

Myositis Autoantigen Expression Correlates With Muscle Regeneration but Not Autoantibody Specificity.

Pinal-Fernandez I, Amici DR, Parks CA, Derfoul A, Casal-Dominguez M, Pak K, Yeker R, Plotz P, Milisenda JC, Grau-Junyent JM, Selva-O'Callaghan A, Paik JJ, Albayda J, Corse AM, Lloyd TE, Christopher-Stine L, Mammen AL.

Arthritis Rheumatol. 2019 Aug;71(8):1371-1376. doi: 10.1002/art.40883. Epub 2019 Jun 18.

PMID:
30861336
10.

Sonographic findings from inflammatory arthritis due to antisynthetase syndrome.

Miller JB, Danoff SK, Bingham CO 3rd, Paik JJ, Mecoli CA, Tiniakou E, Christopher-Stine L, Albayda J.

Clin Rheumatol. 2019 May;38(5):1477-1483. doi: 10.1007/s10067-019-04471-y. Epub 2019 Feb 27.

PMID:
30810913
11.

Muscle disease in scleroderma.

Paik JJ.

Curr Opin Rheumatol. 2018 Nov;30(6):576-580. doi: 10.1097/BOR.0000000000000552. Review.

PMID:
30148800
12.

Febrile Calcinosis in Scleroderma.

Gelber AC, Brener MI, O'Connell K, Wu M, Paik JJ, Albayda JF.

Am J Med. 2018 Dec;131(12):e500-e501. doi: 10.1016/j.amjmed.2018.07.019. Epub 2018 Aug 1. No abstract available.

PMID:
30076824
13.

Muscle endurance deficits in myositis patients despite normal manual muscle testing scores.

Amici DR, Pinal-Fernandez I, Pagkatipunan R, Mears A, de Lorenzo R, Tiniakou E, Albayda J, Paik JJ, Lloyd TE, Christopher-Stine L, Mammen AL, Chung T.

Muscle Nerve. 2019 Jan;59(1):70-75. doi: 10.1002/mus.26307. Epub 2018 Dec 18.

PMID:
30028529
14.

Pattern of muscle involvement in inclusion body myositis: a sonographic study.

Albayda J, Christopher-Stine L, Bingham Iii CO, Paik JJ, Tiniakou E, Billings S, Uy OM, Burlina P.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6):996-1002. Epub 2018 May 8.

15.

Muscular and extramuscular clinical features of patients with anti-PM/Scl autoantibodies.

De Lorenzo R, Pinal-Fernandez I, Huang W, Albayda J, Tiniakou E, Johnson C, Milisenda JC, Casal-Dominguez M, Corse AM, Danoff SK, Christopher-Stine L, Paik JJ, Mammen AL.

Neurology. 2018 Jun 5;90(23):e2068-e2076. doi: 10.1212/WNL.0000000000005638. Epub 2018 May 4.

16.

Determining the Risk Factors and Clinical Features Associated With Severe Gastrointestinal Dysmotility in Systemic Sclerosis.

McMahan ZH, Paik JJ, Wigley FM, Hummers LK.

Arthritis Care Res (Hoboken). 2018 Sep;70(9):1385-1392. doi: 10.1002/acr.23479. Epub 2018 Aug 6.

17.

Inflammatory myopathy associated with anti-mitochondrial antibodies: A distinct phenotype with cardiac involvement.

Albayda J, Khan A, Casciola-Rosen L, Corse AM, Paik JJ, Christopher-Stine L.

Semin Arthritis Rheum. 2018 Feb;47(4):552-556. doi: 10.1016/j.semarthrit.2017.06.004. Epub 2017 Jun 13.

18.

Association of Fibrosing Myopathy in Systemic Sclerosis and Higher Mortality.

Paik JJ, Wigley FM, Shah AA, Corse AM, Casciola-Rosen L, Hummers LK, Mammen AL.

Arthritis Care Res (Hoboken). 2017 Nov;69(11):1764-1770. doi: 10.1002/acr.23291.

19.

A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies.

Pinal-Fernandez I, Casal-Dominguez M, Huapaya JA, Albayda J, Paik JJ, Johnson C, Silhan L, Christopher-Stine L, Mammen AL, Danoff SK.

Rheumatology (Oxford). 2017 Jun 1;56(6):999-1007. doi: 10.1093/rheumatology/kex021.

20.

Independent Association of Severity of Muscle Weakness With Disability as Measured by the Health Assessment Questionnaire Disability Index in Scleroderma.

Paik JJ, Wigley FM, Mejia AF, Hummers LK.

Arthritis Care Res (Hoboken). 2016 Nov;68(11):1695-1703. doi: 10.1002/acr.22870. Epub 2016 Oct 9.

21.

Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity.

Pinal-Fernandez I, Casal-Dominguez M, Carrino JA, Lahouti AH, Basharat P, Albayda J, Paik JJ, Ahlawat S, Danoff SK, Lloyd TE, Mammen AL, Christopher-Stine L.

Ann Rheum Dis. 2017 Apr;76(4):681-687. doi: 10.1136/annrheumdis-2016-210198. Epub 2016 Sep 20.

22.

A case of refractory dermatomyositis responsive to tofacitinib.

Paik JJ, Christopher-Stine L.

Semin Arthritis Rheum. 2017 Feb;46(4):e19. doi: 10.1016/j.semarthrit.2016.08.009. Epub 2016 Aug 17. No abstract available.

PMID:
27642158
23.

Myopathy in scleroderma and in other connective tissue diseases.

Paik JJ.

Curr Opin Rheumatol. 2016 Nov;28(6):631-5. doi: 10.1097/BOR.0000000000000336. Review.

PMID:
27548651
24.

Statin-Induced Anti-HMGCR-Associated Myopathy.

Basharat P, Lahouti AH, Paik JJ, Albayda J, Pinal-Fernandez I, Bichile T, Lloyd TE, Danoff SK, Casciola-Rosen L, Mammen AL, Christopher-Stine L.

J Am Coll Cardiol. 2016 Jul 12;68(2):234-5. doi: 10.1016/j.jacc.2016.04.037. No abstract available.

25.

Thrombotic complications after radial arterial line placement in systemic sclerosis: A case series.

Paik JJ, Hirpara R, Heller JA, Hummers LK, Wigley FM, Shah AA.

Semin Arthritis Rheum. 2016 Oct;46(2):196-199. doi: 10.1016/j.semarthrit.2016.03.015. Epub 2016 Mar 31.

26.

Symptomatic and Electrodiagnostic Features of Peripheral Neuropathy in Scleroderma.

Paik JJ, Mammen AL, Wigley FM, Shah AA, Hummers LK, Polydefkis M.

Arthritis Care Res (Hoboken). 2016 Aug;68(8):1150-7. doi: 10.1002/acr.22818.

27.

Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis.

Lambert AA, Lam JO, Paik JJ, Ugarte-Gil C, Drummond MB, Crowell TA.

PLoS One. 2015 Jun 4;10(6):e0128004. doi: 10.1371/journal.pone.0128004. eCollection 2015. Review.

28.

Spectrum of Muscle Histopathologic Findings in Forty-Two Scleroderma Patients With Weakness.

Paik JJ, Wigley FM, Lloyd TE, Corse AM, Casciola-Rosen L, Shah AA, Boin F, Hummers LK, Mammen AL.

Arthritis Care Res (Hoboken). 2015 Oct;67(10):1416-25. doi: 10.1002/acr.22620.

29.

The composition of cellular infiltrates in anti-HMG-CoA reductase-associated myopathy.

Chung T, Christopher-Stine L, Paik JJ, Corse A, Mammen AL.

Muscle Nerve. 2015 Aug;52(2):189-95. doi: 10.1002/mus.24642. Epub 2015 May 14.

30.

Hickam's dictum and the rare convergence of antisynthetase syndrome and hemoglobin SC disease.

Wilkinson ST, Grunwald MR, Paik JJ, Ostrow LW, Gelber AC.

QJM. 2015 Sep;108(9):735-7. doi: 10.1093/qjmed/hcu242. Epub 2014 Dec 16. No abstract available.

31.

Myopathy in scleroderma, its identification, prevalence, and treatment: lessons learned from cohort studies.

Paik JJ, Mammen AL, Wigley FM, Gelber AC.

Curr Opin Rheumatol. 2014 Mar;26(2):124-30. doi: 10.1097/BOR.0000000000000024. Review.

PMID:
24419752
32.

The co-existence of myasthenia gravis in patients with myositis: a case series.

Paik JJ, Corse AM, Mammen AL.

Semin Arthritis Rheum. 2014 Jun;43(6):792-6. doi: 10.1016/j.semarthrit.2013.12.005. Epub 2013 Dec 18.

33.

Ibuprofen intervention in canine septic shock: reduction of pathophysiology without decreased cytokines.

Coran AG, Drongowski RA, Paik JJ, Remick DG.

J Surg Res. 1992 Sep;53(3):272-9.

Supplemental Content

Support Center